name: {2 (20 ML) (iodine-131-tositumomab 1.1 MG/ML Injectable Solution) / 2 (16.1 ML) (tositumomab 14 MG/ML Injectable Solution) } Pack [Bexxar Therapeutic Packaging]


name: Aluminum Chloride 21.3% Topical application Swab


name: Octinoxate/Oxybenzone 6.4%-5.4% Topical application Ointment


name: Class Act Ultra Thin & Sensitive Lubricated


name: Prodigy Duo Blood Glucose/Blood Pressure Mete


name: Scot-Tussin Multi-Action Cold and Allergy


name: Trojan Ultra Ribbed Spermicidal Lubricated


name: Trojan Ultra Thin Spermicidal Lubricated


name: needles, safety 27 gauge X 5/8" MISCELL NEEDLE, DISPOSABLE


name: syringe with cannula, disposable, 10 mL 17 gauge MISCELL SYRINGE, EMPTY DISPOSABLE


name: sub-q infusion pump w/continuous glucose monitor


name: Paradigm Silhouette Infusion 13MM Full Set-32 inch


name: Paradigm Quick-set Infusion Set 9MM-32 inch


name: Paradigm Quick-set Infusion Set 6MM-32 inch


name: Decompression - action (qualifier value)


name: Simple new 15 minutes in-office midwifery intake


name: Usual new 30 minutes in-office midwifery intake


name: Detailed new 45 minutes in-office midwifery intake


name: Comprehensive new 60 minutes in-office midwifery intake


name: Comprehensive prolonged new 180 minutes in-office homeopathic intake


name: Simple subsequent 15 minutes in-office midwifery intake


name: Usual subsequent 30 minutes in-office midwifery intake


name: Detailed subsequent 45 minutes in-office midwifery intake


name: Comprehensive subsequent 60 minutes in-office midwifery intake


name: Simple new out-of-office 15 minutes midwifery intake


name: Usual new out-of-office 30 minutes midwifery intake


name: Detailed new out-of-office 45 minutes midwifery intake


name: Comprehensive new out-of-office 60 minutes midwifery intake


name: Comprehensive prolonged new out-of-office 180 minutes homeopathic intake


name: Comprehensive new home visit 60 minutes homeopathic intake


name: Comprehensive prolonged new home visit 90 minutes homeopathic intake


name: Comprehensive prolonged new home visit 120 minutes homeopathic intake


name: Comprehensive prolonged new home visit 150 minutes homeopathic intake


name: Comprehensive prolonged new home visit 180 minutes homeopathic intake


name: Simple subsequent out-of-office 15 minutes midwifery intake


name: Usual subsequent out-of-office 30 minutes midwifery intake


name: Detailed subsequent out-of-office 45 minutes midwifery intake


name: Comprehensive subsequent out-of-office 60 minutes midwifery intake


name: New client in-facility with or without ICD diagnosis


name: In-facility simple new nutrition intake 10 minutes


name: In-facility usual new nutrition intake 20 minutes


name: In-facility detailed new nutrition intake 30 minutes


name: Existing client in-facility with or without ICD diagnosis


name: Detailed 30 minute new phone consult homeopathic intake


name: Detailed 45 minute new phone consult homeopathic intake


name: Comprehensive 60 minute new phone consult homeopathic intake


name: Comprehensive prolonged 90 minute new phone consult homeopathic intake


name: Comprehensive prolonged 120 minute new phone consult homeopathic intake


name: Comprehensive prolonged 150 minute new phone consult homeopathic intake


name: Comprehensive prolonged 180 minute new phone consult homeopathic intake


name: Simple subsequent 15 minute follow-up phone consult homeopathic intake


name: Detailed subsequent 30 minute follow-up phone consult homeopathic intake


name: Detailed subsequent 45 minute follow-up phone consult homeopathic intake


name: Comprehensive subsequent 60 minute follow-up phone consult homeopathic intake


name: Comprehensive prolonged subsequent 90 minute follow-up phone consult homeopathic intake


name: Non-specified burn treatment reference code no charge


name: Non-specified spinal procedure reference code no charge


name: Non-specified cast and/or splint supply and/or procedure reference code no charge


name: Non-specified digestive system procedure reference code no charge


name: Non-specified HCPCS II dental service diagnostic procedure reference code no charge


name: Non-specified HCPCS II vision procedure reference code no charge


name: Non-specified HCPCS II durable medical equipment reference code no charge


name: Non-specified HCPCS II home health or personal care service or procedure reference code no charge


name: Non-specified HCPCS II orthotic procedure, equipment or supply reference code no charge


name: Non-specified HCPCS II binding procedure or supply reference code no charge


name: Non-specified HCPCS II foot procedure reference code no charge


name: Non-specified HCPCS II hospital service or procedure reference code no charge


name: Non-specified HCPCS II adult care procedure reference code no charge


name: Non-specified HCPCS II prescriptive or non-prescriptive drug and/or prescription item reference code no charge


name: Non-specified HCPCS II emergency or non-emergency transportation, travel, or delivery expense or service reference code no charge


name: Non-specified HCPCS II reproductive service reference code no charge


name: Non-specified HCPCS II referral, evaluation and/or assessment reference code no charge


name: Non-specified HCPCS II transplant service or procedure reference code no charge


name: Non-specified HCPCS II radiology service or procedure reference code no charge


name: Non-specified HCPCS II surgical procedure reference code no charge


name: Non-specified HCPCS II metabolic procedure reference code no charge


name: Non-specified HCPCS II home infusion service or procedure reference code no charge


name: Non-specified HCPCS II infant or child care or safety service reference code no charge


name: Non-specified HCPCS II sleep service or procedure reference code no charge


name: Non-specified HCPCS II speech and/or hearing therapy service or procedure reference code no charge


name: Non-specified HCPCS II behavioral health service or procedure reference code no charge


name: Non-specified HCPCS II training, education or behavior modification service or procedure reference code no charge


name: Non-specified HCPCS II registered nurse service or procedure reference code no charge


name: Non-specified HCPCS II LVN/LPN nurse service or procedure reference code no charge


name: Non-specified HCPCS II caregiver other than nurse or physician service or procedure reference code no charge


name: Non-specified HCPCS II telehealth transmission or procedure reference code no charge


name: Non-specified HCPCS II environmental management service or procedure reference code no charge


name: Non-specified HCPCS II case management and/or evaluation service reference code no charge


name: Nutritional therapy individual each 15 minutes


name: Integral practice therapy each 15 minutes


name: Spinal adjustment two regions each adjustment


name: Spinal adjustment three regions each adjustment


name: Spinal adjustment four regions each adjustment


name: Spinal adjustment all regions each adjustment


name: Spinal device adjustment two regions each adjustment


name: Spinal device adjustment three regions each adjustment


name: Spinal device adjustment four regions each adjustment


name: Spinal device adjustment all regions each adjustment


name: Bombyx processionea (homeopathic preparation)


name: Nonspinal adjustment two or more regions each adjustment


name: Nonspinal device adjustment two or more regions each adjustment


name: Acromioclavicular device adjustment each adjustment


name: Cranial device adjustment each adjustment


name: Hip joint device adjustment each adjustment


name: Knee joint device adjustment each adjustment


name: Lunate device adjustment each adjustment


name: Patella device adjustment each adjustment


name: Radiocarpal device adjustment each adjustment


name: Scaphoid through lunate device adjustment each adjustment


name: Shoulder device adjustment each adjustment


name: Sternoclavicular device adjustment each adjustment


name: Temporomandibular joint device adjustment each adjustment


name: Toe joint device adjustment each adjustment


name: Multiple mental and/or behavioral health services individual daily rate 4 to 8 hours


name: Multiple mental and/or behavioral health services individual daily rate over 8 hours


name: Elder abuse protection family each 15 minutes


name: Suicide risk reduction group each 60 minutes


name: Germanium metallicum homeopathic preparation


name: Recreation therapy assistance individual each 15 minutes


name: Recreation therapy assistance group each 60 minutes


name: Wound dressing preparation each 5 minutes


name: Nursing care quality monitoring each 15 minutes


name: Lower extremity monitoring each 15 minutes


name: Dialysis access maintenance each 15 minutes


name: Bioterrorism and/or disaster preparedness education group each 60 minutes


name: Christian Science treatment face-to-face each 5 minutes


name: Recreational spiritual care individual each 15 minutes


name: Recreational spiritual care group each 15 minutes


name: Comprehensive Wellness Panel (CWP) each test


name: Artemisia abrotanum (homeopathic remedy)


name: Astacus fluviatilis (homeopathic remedy)


name: Hydrophis cyanocinctus (homeopathic remedy)


name: Oncorhynchus tshawytscha (homeopathic remedy)


name: Sequoia sempervirens (homeopathic remedy)


name: Avobenzone/Homosalate/Octisalate/Oxybenzone 3%-15%-5%-6% Topical application Spray


name: chlorophyllin copper complex / papain / urea


name: CitraNatal DHA, Prenatal Multivitamins with Folic Acid 1 mg oral kit


name: Gas-X Tongue Twisters Thin Strips Children's


name: HalfLytely and Bisacodyl with Flavor Packs


name: fibrin sealant topical 10 mL topical kit


name: adhesive bandage 1" X 3 1/4" TOPICAL BANDAGE


name: assembly system, vial to transfer device, closed system MISCELL EACH


name: assembly sys,vial to transfer device,closed system


name: connector luer lock, closed system MISCELL EACH


name: desoximetasone, micronized 100 % MISCELL POWDER (GRAM)


name: infusion adapter, closed system MISCELL EACH


name: needle injector, luer lock, closed system MISCELL EACH


name: needle injector, luer, closed system MISCELL EACH


name: prenatal vit no.19/iron bg HCl,suc-prot/folic acid/omega-3 29 mg iron-1 mg-400 mg ORAL COMBINATION PACKAGE, TABLET AND DR CAP


name: Transcutaneous Electrical Nerve Stimulators (TENS Units) MISCELL EACH


name: thermometer, temple electronic MISCELL EACH


name: thrombin(bov)/calcium chlor/cmc/gel,pork/dressing,hemostatic 10 cm2 TOPICAL PADS, MEDICATED (EA)


name: thrombin(bov)/calcium chlor/cmc/gel,pork/dressing,hemostatic 100 cm2 TOPICAL PADS, MEDICATED (EA)


name: thrombin(bov)/calcium chlor/cmc/gel,pork/dressing,hemostatic 40 cm2 TOPICAL PADS, MEDICATED (EA)


name: transfer device, closed system 13 mm MISCELL EACH


name: transfer device, closed system 20 mm MISCELL EACH


name: transfer device, closed system 28 mm MISCELL EACH


name: y-site line connector, closed system MISCELL EACH


name: Guardian REAL-Time Replacement Pediatric Monitor


name: Exelint Comfort Point 1ML 30G 5/16 inch Insulin Syringe


name: Exelint Comfort Point 1/2ML 28G 1/2 inch Lo-Dose Insulin Syringe


name: Heparin Lock Flush, 2 units/mL intravenous solution


name: BD Insulin Syringe 0.3cc 31g 5/16" (UF II)


name: BD Insulin Syringe 0.5cc 31g 5/16" (UF II)


name: BD Insulin Syringe 1cc 31g 5/16" (UF II)


name: RINNOVI with Urea 50% QUINNOSTIK Nail System


name: Rosula CLK, 10%-4%-10% with sunscreen topical kit


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Tilia Fe]


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Tri-Legest 28 Day]


name: sulfacetamide sodium/sulfur/urea topical 10%-4%-10% with sunscreen topical kit


name: urea topical 50% with cleanser and protectant topical kit


name: {10 (chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG Extended Release Oral Tablet) / 10 (methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet) } Pack [VisRx Dosepack 10]


name: Citric Acid/Dextrose/Sodium Citrate/Sodium Phosphate 299 MG/100 ML-2.55 GM/100 ML-2.63 GM/100 ML-222 MG/100 ML Intravenous Solution [ANTICOAGULANT CPD]


name: compression stocking,knee high,long length, large circumfer. MISCELL EACH


name: compression stocking,knee high,long length,medium circumfer. MISCELL EACH


name: compression stocking,knee high,long length, x-large circumf. MISCELL EACH


name: compression stocking,knee high,regular length,large circumf. MISCELL EACH


name: compression stocking, knee high, regular length, medium MISCELL EACH


name: compression stocking, knee high, regular length, small MISCELL EACH


name: compression stocking,thigh high,long length,large circumfer. MISCELL EACH


name: compression stocking,thigh high,long length,medium circumfer MISCELL EACH


name: compression stocking,thigh high,long length,small circumfer. MISCELL EACH


name: compression stocking,thigh high,long length,extra-large circ MISCELL EACH


name: compression stocking,thigh high,long length,x-small circumf. MISCELL EACH


name: compression stocking,thigh high,regular length,large circumf MISCELL EACH


name: compression stocking,thigh high,regular length,medium circum MISCELL EACH


name: compression stocking,thigh high,regular length,small circumf MISCELL EACH


name: compression stocking,thigh high,reg length,x-large circumfer MISCELL EACH


name: compression stocking,thigh high,regular length,x-small circ. MISCELL EACH


name: compression stocking,thigh high,short length,large circumfer MISCELL EACH


name: compression stocking,thigh high,short length,medium circumf. MISCELL EACH


name: compression stocking,thigh high,short length,small circumfer MISCELL EACH


name: compression stocking,knee high,long length,small circumferen MISCELL EACH


name: compression stocking,knee high,regular length,x-large circum MISCELL EACH


name: compress. stocking,knee high, long length, medium


name: compress. stocking,knee high, long length, small


name: elastic bandage 2" X 6 yard TOPICAL BANDAGE


name: ketoprofen, micronized 100 % MISCELL POWDER (GRAM)


name: tens unit electrodes 2" X 2" MISCELL EACH


name: FreeStyle Flash Blood Glucose Monitor Kit


name: FreeStyle Lite Blood Glucose Monitor Kit


name: Precision SureDose 3/10ML 29G 1/2 inch Insulin Syringe


name: FreeStyle Freedom Blood Glucose Monitor Kit


name: {5 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ethinyl estradiol 0.03 MG / norethindrone acetate 1 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: {28 (estradiol 0.5 MG / norethindrone acetate 0.1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {28 (drospirenone 0.5 MG / estradiol 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {6 (ethinyl estradiol 0.03 MG / levonorgestrel 0.05 MG Oral Tablet) / 10 (ethinyl estradiol 0.03 MG / levonorgestrel 0.125 MG Oral Tablet) / 5 (ethinyl estradiol 0.04 MG / levonorgestrel 0.075 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {11 (varenicline 0.5 MG Oral Tablet) / 42 (varenicline 1 MG Oral Tablet) } Pack


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.01 MG Oral Tablet) / 84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) } Pack


name: {1 (acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {56 (varenicline 1 MG Oral Tablet) } Pack


name: {15 (estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (estradiol 1 MG Oral Tablet) } Pack


name: {7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {10 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 11 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {7 (inert ingredients 1 MG Oral Tablet) / 21 (mestranol 0.05 MG / norethindrone 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack


name: SLC35A1, 2-BP DEL, 277G AND 281C, AND 147T-C


name: FOXL2, 15-BP DUP, NT684, ALANINE TRACT EXPANSION


name: STAT5B, 1-BP DEL, EXON 13/INTRON 13 JUNCTION


name: CHIT1, GLY354ARG, LEU385LEU, AND 4-BP DEL


name: Myringotomy and insertion of tympanic ventilation tube


name: Esophagus (including hiatus hernia) operations NOS (procedure)


name: Insertion of catheter into urinary bladder


name: Blood ketone test or reagent strip, each


name: Cervical traction device, with inflatable air bladder(s)


name: Manual wheelchair accessory, gear reduction drive wheel, each


name: Manual wheelchair accessory, wheel braking system and lock, complete, each


name: Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware


name: Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each


name: Power wheelchair accessory, lithium-based battery, each


name: Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes


name: Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes


name: Left ventricular ejection fraction (lvef) not performed or documented


name: Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy


name: Lower extremity neurological exam performed and documented


name: Lower extremity neurological exam not performed


name: Footwear evaluation performed and documented


name: Clinician documented that patient was not an eligible candidate for footwear evaluation measure


name: Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an urgent or emergent medical situation)


name: Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons)


name: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed


name: Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons)


name: ONCOLOGY; DISEASE STATUS; INVASIVE FEMALE BREAST CANCER (DOES NOT INCLUDE DUCTAL CARCINOMA IN SITU); ADENOCARCINOMA AS PREDOMINANT CELL TYPE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; PROSTATE CANCER, LIMITED TO ADENOCARCINOMA; HORMONE-REFRACTORY/ANDROGEN-INDEPENDENT (E.G., RISING PSA ON ANTI-ANDROGEN THERAPY OR POST-ORCHIECTOMY); CLINICAL METASTASES (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; STAGE I, II AT DIAGNOSIS, NOT RELAPSED, NOT REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; STAGE III, IV, NOT RELAPSED, NOT REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, TRANSFORMED FROM ORIGINAL CELLULAR DIAGNOSIS TO A SECOND CELLULAR CLASSIFICATION (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; RELAPSED/REFRACTORY (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; NON-HODGKIN'S LYMPHOMA, ANY CELLULAR CLASSIFICATION; DIAGNOSTIC EVALUATION, STAGE NOT DETERMINED, EVALUATION OF POSSIBLE RELAPSE OR NON-RESPONSE TO THERAPY, OR NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: ONCOLOGY; DISEASE STATUS; CHRONIC MYELOGENOUS LEUKEMIA, LIMITED TO PHILADELPHIA CHROMOSOME POSITIVE AND/OR BCR-ABL POSITIVE; EXTENT OF DISEASE UNKNOWN, STAGING IN PROGRESS, NOT LISTED (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT)


name: Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours


name: Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment


name: Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric


name: Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric


name: Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric


name: Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric


name: Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined


name: Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined


name: Physician management of patient home care, standard monthly case rate (per 30 days)


name: Physician management of patient home care, hospice monthly case rate (per 30 days)


name: Physician management of patient home care, episodic care monthly case rate (per 30 days)


name: Physician visit at member's home, outside of a capitation arrangement


name: Nurse practitioner visit at member's home, outside of a capitation arrangement


name: Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral


name: Breast reconstruction of a single breast with "stacked" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral


name: Genetic testing for amyotrophic lateral sclerosis (als)


name: Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit


name: Astigmatism correcting function of intraocular lens


name: Performance measure reporting modifier-action not performed, reason not otherwise specified


name: Tissue marker, implantable, any type, each


name: Continent device, stoma absorptive cover for continent stoma


name: Adhesive bandage, first-aid type, any size, each


name: COMBINATION ORAL/NASAL MASK, USED WITH CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICE, EACH


name: Oral cushion for combination oral/nasal mask, replacement only, each


name: Nasal pillows for combination oral/nasal mask, replacement only, pair


name: External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories


name: Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply


name: Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system


name: Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system


name: Foot pressure off loading/supportive device, any type, each


name: Injection, gadoteridol, (prohance multipack), per ml


name: Injection, gadobenate dimeglumine (multihance), per ml


name: Injection, gadobenate dimeglumine (multihance multipack), per ml


name: Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml


name: Gastrostomy/jejunostomy tube, standard, any material, any type, each


name: Gastrostomy/jejunostomy tube, low-profile, any material, any type, each


name: Comprehensive preoperative assessment performed for cataract surgery with intraocular lens (IOL) placement (includes assessment of all of the following components) (EC): Dilated fundus evaluation performed within 12 months prior to cataract surgery (2020F) Pre-surgical (cataract) axial length, corneal power measurement and method of intraocular lens power calculation documented (must be performed within 12 months prior to surgery) (3073F) Preoperative assessment of functional or medical indication(s) for surgery prior to the cataract surgery with intraocular lens placement (must be performed within 12 months prior to cataract surgery) (3325F)


name: Melanoma follow up completed (includes assessment of all of the following components) (ML): History obtained regarding new or changing moles (1050F) Complete physical skin exam performed (2029F) Patient counseled to perform a monthly self skin examination (5005F)


name: Elevated blood pressure plan of care documented (CKD)


name: Plan of care for elevated hemoglobin level documented for patient receiving Erythropoiesis-Stimulating Agent therapy (ESA) (CKD)


name: Planned chemotherapy regimen, including at a minimum: drug(s) prescribed, dose, and duration, documented prior to initiation of a new treatment regimen (ONC)


name: Radiation dose limits to normal tissues established prior to the initiation of a course of 3D conformal radiation for a minimum of 2 tissue/organ (ONC)


name: Plan of care to address pain documented (COA) (ONC)


name: Auricular or periauricular pain assessed (AOE)


name: GERD symptoms assessed after 12 months of therapy (GERD)


name: Initial evaluation for condition (HEP C) (EPI, DSP)


name: Subsequent evaluation for condition (HEP C) (EPI)


name: Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr)


name: Advance Care Planning discussed and documented in the medical record, patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan (DEM) (GER, Pall Cr)


name: Pain severity quantified; pain present (COA) (ONC)


name: Pain severity quantified; no pain present (COA) (ONC)


name: New episode for condition (NMA-No Measure Associated)


name: Tympanic membrane mobility assessed with pneumatic otoscopy or tympanometry (OME)


name: RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C)


name: Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C)


name: Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C)


name: Prostate-specific antigen (PSA), and primary tumor (T) stage, and Gleason score documented prior to initiation of treatment (PRCA)


name: Bone scan performed prior to initiation of treatment or at any time since diagnosis of prostate cancer (PRCA)


name: Serum levels of calcium, phosphorus, intact Parathyroid Hormone (PTH) and lipid profile ordered (CKD)


name: American Joint Committee on Cancer (AJCC) stage documented and reviewed (ONC)


name: Cancer stage documented in medical record as metastatic and reviewed (ONC)


name: Pathology report confirming malignancy documented in the medical record and reviewed prior to the initiation of chemotherapy (ONC)


name: Pathology report confirming malignancy documented in the medical record and reviewed prior to the initiation of radiation therapy (onc)


name: 1 of the following diagnostic imaging studies ordered: chest x-ray, CT, Ultrasound, MRI, PET, or nuclear medicine scans (ML)


name: Preoperative assessment of functional or medical indication(s) for surgery prior to the cataract surgery with intraocular lens placement (must be performed within 12 months prior to cataract surgery) (EC)


name: Topical preparations (including OTC) prescribed for acute otitis externa (AOE)


name: Systemic antimicrobial therapy prescribed (AOE)


name: Systemic antimicrobial therapy not prescribed (AOE)


name: Antihistamines or decongestants prescribed or recommended (OME)


name: Antihistamines or decongestants neither prescribed nor recommended (OME)


name: Systemic corticosteroids prescribed (OME)


name: Patient receiving antiviral treatment for Hepatitis C (HEP-C)


name: Patient did not start or is not receiving antiviral treatment for Hepatitis C during the measurement period (HEP-C)


name: Combination peginterferon and ribavirin therapy prescribed (HEP-C)


name: Hepatitis A vaccine series previously received (HEP-C)


name: Hepatitis B vaccine series previously received (HEP-C)


name: Patient counseled about risks of alcohol use (HEP-C)


name: Counseling regarding contraception received prior to initiation of antiviral treatment (HEP-C)


name: Patient counseling at a minimum on all of the following treatment options for clinically localized prostate cancer: active surveillance, and interstitial prostate brachytherapy, and external beam radiotherapy, and radical prostatectomy, provided prior to initiation of treatment (PRCA)


name: Adjuvant (ie, in combination with external beam radiotherapy to the prostate for prostate cancer) hormonal therapy (gonadotropin-releasing hormone [GnRH] agonist or antagonist) prescribed/administered (PRCA)


name: 3-dimensional conformal radiotherapy (3D-CRT) or intensity modulated radiation therapy (IMRT) received (PRCA)


name: Head of bed elevation (30-45 degrees) on first ventilator day ordered (CRIT)


name: Patient receiving care in the intensive care unit (ICU) and receiving mechanical ventilation, 24 hours or less (CRIT)


name: Patient either not receiving care in the intensive care unit (ICU) OR not receiving mechanical ventilation OR receiving mechanical ventilation greater than 24 hours (CRIT)


name: Patient receiving erythropoiesis-stimulating agents (ESA) therapy (CKD)


name: Patient not receiving erythropoiesis-stimulating agents (ESA) therapy (CKD)


name: Counseling about the potential impact of glaucoma on visual functioning and quality of life, and importance of treatment adherence provided to patient and/or caregiver(s) (EC)


name: Counseling about value of protection from UV light and lack of proven efficacy of nutritional supplements in prevention or progression of cataract development provided to patient and/or caregiver(s) (NMA-No Measure Associated)


name: Counseling about the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formulation for preventing progression of age-related macular degeneration (AMD) provided to patient and/or caregiver(s) (EC)


name: Anti-D immune globulin received between 26 and 30 weeks gestation (Pre-Cr)


name: Tamoxifen or aromatase inhibitor (AI) prescribed (ONC)


name: Adjuvant chemotherapy referred, prescribed, or previously received for Stage III colon cancer (ONC)


name: Conformal radiation therapy not received (NMA-No Measure Associated)


name: Continuous (12-months) therapy with proton pump inhibitor (PPI) or histamine H2 receptor antagonist (H2RA) received (GERD)


name: No continuous (12-months) therapy with either proton pump inhibitor (PPI) or histamine H2 receptor antagonist (H2RA) received (GERD)


name: Disease modifying anti-rheumatic drug therapy prescribed or dispensed (RA)


name: Appropriate angiotensin converting enzyme (ACE)/angiotensin receptor blockers (ARB) therapeutic monitoring test ordered or performed (AM)


name: Appropriate digoxin therapeutic monitoring test ordered or performed (AM)


name: Appropriate diuretic therapeutic monitoring test ordered or performed (AM)


name: Appropriate anticonvulsant therapeutic monitoring test ordered or performed (AM)


name: External beam radiotherapy as primary therapy to prostate with or without nodal irradiation (PRCA)


name: External beam radiotherapy with or without nodal irradiation as adjuvant or salvage therapy for prostate cancer patient (PRCA)


name: Angiotensin converting enzyme (ACE) or angiotensin receptor blockers (ARB) medication therapy for 6 months or more (MM)


name: Digoxin medication therapy for 6 months or more (MM)


name: Diuretic medication therapy for 6 months or more (MM)


name: Anticonvulsant medication therapy for 6 months or more (MM)


name: Treatment plan communicated to provider(s) managing continuing care within 1 month of diagnosis (ML)


name: All elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed (CRIT)


name: Patient information entered into a recall system that includes: target date for the next exam specified and a process to follow up with patients regarding missed or unscheduled appointments (ML)


name: Excision of rectal tumor, transanal endoscopic microsurgical approach (ie, TEMS), including muscularis propria (ie, full thickness)


name: Unilateral scanning computerized ophthalmic diagnostic imaging of anterior segment with interpretation and report


name: C Codes - CMS Hospital Outpatient System


name: Temporary National Codes Established by Medicaid


name: Brachytherapy source, stranded, iodine-125, per source


name: Brachytherapy source, non-stranded, iodine-125, per source


name: Brachytherapy source, stranded, palladium-103, per source


name: Brachytherapy source, non-stranded, palladium-103, per source


name: Brachytherapy source, stranded, cesium-131, per source


name: Brachytherapy source, stranded, not otherwise specified, per source


name: Brachytherapy source, non-stranded, not otherwise specified, per source


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study


name: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report


name: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report


name: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis


name: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report


name: Microporous collagen implantable tube (neuragen nerve guide), per centimeter length


name: Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length


name: Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple


name: Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy


name: Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy


name: Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy


name: Partial credit received for replaced device


name: Dmepos item subject to dmepos competitive bidding program number 1


name: Dmepos item subject to dmepos competitive bidding program number 2


name: Beneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid item


name: Dmepos item subject to dmepos competitive bidding program number 3


name: Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service


name: Dmepos item subject to dmepos competitive bidding program number 4


name: Dmepos item subject to dmepos competitive bidding program number 5


name: Investigational clinical service provided in a clinical research study that is in an approved clinical research study


name: Routine clinical service provided in a clinical research study that is in an approved clinical research study


name: Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress


name: Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress


name: Tempo brand of antacid Reformulated Feb 2009


name: Other current diagnoses & ICD9 codes (quarterly)


name: Outpatient encounter-level information section:-:Pt:^Patient:Set:HIV-ART


name: Antiretroviral therapy status section:-:Pt:^Patient:Set:HIV-ART


name: HIV care & family status section:-:Pt:^Patient:Set:HIV-ART


name: Number of hospital D since last outpatient visit:Num:Pt:^Patient:Qn:Reported


name: Evidence of tuberculosis resistance:Find:Pt:^Patient:Nom:Reported


name: human immunodeficiency virus confirmation facility


name: Institutional entry point HIV Rx:Type:Pt:Facility:Nom:Reported


name: HIV Rx prior clinic transferred from:Addr:Pt:Facility:Nom:Reported


name: HIV Rx prior clinic transferred from:ID:Pt:Facility:Nom:Reported


name: PHQ-9: quick depression assessment panel


name: District where patient entered HIV Rx:ID:Pt:^Patient:Nom:Reported


name: HIV Rx prior to enrollment:Type:Pt:^Patient:Nom:Reported


name: Reason medically eligible for HIV Rx:Find:Pt:^Patient:Nom:Reported


name: Date eligible and selected to start HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Date eligible and selected to start HIV Rx


name: Date original clinic HIV Rx start:Date:Pt:^Patient:Qn:Reported


name: Date original clinic human immunodeficiency virus Rx start


name: Date lost to HIV Rx follow-up:Date:Pt:^Patient:Qn:Reported


name: Date lost to human immunodeficiency virus Rx follow-up


name: Date lost to HIV Rx therapy:Date:Pt:^Patient:Qn:Reported


name: Date lost to human immunodeficiency virus Rx therapy


name: Current HIV Rx therapy duration:Time:Pt:^Patient:Qn:Computed


name: Isoniazid therapy start date:Date:Pt:^Patient:Qn:Reported


name: Tuberculosis treatment start date:Date:Pt:^Patient:Qn:Reported


name: Reason for discontinuation of anti-infective phrophylaxis medication:Type:Pt:^Patient:Nom:Reported


name: HIV ART medication dose number taken/Medication dose number prescribed:NFr:Pt:^Patient:Qn:Reported


name: HIV ART medication dose number taken/Medication dose number prescribed


name: Degree of adherence to co-trimoxazole:Find:Pt:^Patient:Ord:Reported


name: Degree of adherence to anti-retroviral drug regimen:Find:Pt:^Patient:Ord:Reported


name: Reason for missing HIV Rx administration schedule:Find:Pt:^Patient:Nom:Reported


name: HIV Rx clinic transferred to:Addr:Pt:Facility:Nom:Reported


name: HIV Rx clinic transferred to:ID:Pt:Facility:Nom:Reported


name: Date dropped from HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Date dropped from human immunodeficiency virus Rx


name: HIV ART medication dose number taken/Medication dose number prescribed:NFr:Pt:^Patient:Qn:MEMS Cap


name: HIV ART actual prescription fills number/Ideal prescription fills number:NFr:Pt:^Patient:Qn:Pharmacy records


name: HIV ART actual prescription fills number/Ideal prescription fills number


name: human immunodeficiency virus ART medication


name: {HIV ART medication} doses missed yesterday:Num:Pt:^Patient:Qn:Reported.ACTG


name: {HIV ART medication} doses missed 2D ago:Num:Pt:^Patient:Qn:Reported.ACTG


name: {HIV ART medication} doses missed 3D ago:Num:Pt:^Patient:Qn:Reported.ACTG


name: {HIV ART medication} doses missed 4D ago:Num:Pt:^Patient:Qn:Reported.ACTG


name: Date of last day of MDS observation period


name: Medicaid resident liability or Medicare copayment


name: Alterability of physically abusive behavioral symptoms


name: Alterability of socially inappropriate or disruptive behavioral symptoms


name: Other current or more detailed diagnoses & ICD9 codes


name: Plate guard, stabilized built-up utensil, etc.


name: Training in skills required to return to the community


name: Nutrition or hydration intervention to manage skin problems


name: Application of dressings (with or without topical medications) other than to feet


name: Application of ointments or medications other than to feet


name: Application of dressings (foot) - with or without topical medications


name: Special behavior symptom evaluation program


name: Through D 15, provide an estimate of the number of D when at least 1 therapy service can be expected to have been delivered


name: Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free:MRto:24H:Urine:Qn


name: Beta F1 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Papova virus SV40 DNA:NCnc:Pt:Stool:Qn:Probe.amp.tar


name: Parvovirus B19 DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Parvovirus B19 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Aspergillus sp Ab:PrThr:Pt:CSF:Ord:Immune diffusion


name: Herpes simplex virus 1+2 Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: 11-Dehydro thromboxane beta 2/Creatinine:MRto:Pt:Urine:Qn


name: FBN1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Reason for stopping HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Date determined medically eligible to start HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Date determined medically eligible and ready to start HIV Rx:Date:Pt:^Patient:Qn:Reported


name: Medication or other side effects associated with HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Severity of side effect to HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Symptom, diagnosis, or opportunistic infection related to HIV Rx:Type:Pt:^Patient:Nom:Reported


name: Glomerular filtration rate/1.73 sq M.predicted.non black


name: Glomerular filtration rate/1.73 sq M.predicted.black


name: 11-Deoxycortisol^2H post dose metyraPONE:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Aldosterone^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Muscle sarcolemma Ab:Titr:Pt:Plr fld:SemiQn:IF


name: ATN1 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: ATN1 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: FXN gene allele 1.GAA repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: FXN gene allele 2.GAA repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: HTT gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: HTT gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: Lymphocyte proliferation.100 umol beryllium stimulation^6D post incubation:Ratio:Pt:Bld:Qn


name: Arterial-mixed venous oxygen saturation difference:MFr:Pt:Bld:Qn


name: Arterial-mixed venous oxygen saturation difference


name: Arterial-venous oxygen saturation difference:MFr:Pt:Bld:Qn


name: Arterial-venous oxygen saturation difference


name: Iron & Iron binding capacity panel:-:Pt:Ser/Plas:Qn


name: Cholesterol.in IDL+Cholesterol.in VLDL 3:MCnc:Pt:Ser/Plas:Qn


name: Varicella zoster virus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Alpha synuclein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Androgen receptor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Annexin 1 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Alzheimer precursor protein Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Beta catenin Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: IgG subclass 4 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cyclooxygenase 2 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Herpes virus 8 latent nuclear Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Vascular endothelial growth factor Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Glucose tolerance^post 75 g glucose PO:Imp:Pt:Ser/Plas:Nar


name: Glucose tolerance^post 100 g glucose PO:Imp:Pt:Ser/Plas:Nar


name: Hepatitis E virus Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldCoA:Qn


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldCoV:Qn


name: Oxygen^^adjusted to patient's actual temperature:PPres:Pt:BldCoA:Qn


name: Oxygen^^adjusted to patient's actual temperature:PPres:Pt:BldCoV:Qn


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldCoA:SemiQn


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldCoV:SemiQn


name: Neural tube defect risk:Likelihood:Pt:^Population:Qn


name: Coagulation surface induced.factor substitution^2H post incubation after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.factor substitution^1H post incubation after 1:4 addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced.factor substitution^after addition of normal plasma 1H post incubation separate tubes:Time:Pt:PPP:Qn:Coag


name: Hepatitis C virus core Ag:PrThr:Pt:Bld/Bone mar^Donor:Ord


name: Herpes simplex virus 1+2 Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Snowshoe hare virus Ab.Neut:PrThr:Pt:XXX:Ord:Neut


name: Advanced oxidation protein products:SCnc:Pt:Ser/Plas:Qn


name: Basal metabolic rate index:ACnc:Pt:^Patient:Qn


name: Glomerular filtration rate/1.73 sq M.predicted.female:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (MDRD)


name: Glomerular basement membrane Ab:ACnc:Pt:Ser:Qn


name: Transforming growth factor beta 1:MCnc:Pt:Ser/Plas:Qn


name: COL5A1 gene+COL5A2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SMN1 gene+SMN2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: (Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Mahogany wood dust Ab.IgE:ACnc:Pt:Ser:Qn


name: Colorado tick fever virus Ab.Neut:PrThr:Pt:XXX:Ord:Neut


name: Calcitonin Calcium & Pentagastrin challenge panel:-:Pt:Ser/Plas:Qn


name: Calcitonin Calcium & Pentagastrin challenge panel


name: Calcitonin^10M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^5M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^2M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^1M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^pre 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Influenza virus A Ab.Neut:Prid:Pt:Ser:Nom:Neut


name: Influenza virus A Ag:Prid:Pt:Isolate:Nom


name: Influenza virus A.adamantane resistance:PrThr:Pt:Isolate:Ord:Phenotyping


name: Influenza virus A.adamantane resistance:PrThr:Pt:Isolate:Ord


name: Influenza virus A.adamantane resistant RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H1 Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus A matrix protein RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Referral lab test identifier and name:ID:Pt:Referral lab test:Nom


name: Trisomy 18 risk cutoff:Find:Pt:^Fetus:Qn


name: Trisomy 21 risk cutoff:Find:Pt:^Fetus:Qn


name: Neural tube defect risk cutoff:Find:Pt:^Fetus:Qn


name: Protein C/Coagulation factor X:MRto:Pt:PPP:Qn


name: Protein S Ag/Coagulation factor X Ag:MRto:Pt:PPP:Qn:Coag


name: SCA1 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA1 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA10 gene allele 1.ATTCT repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA10 gene allele 2.ATTCT repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA2 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SOD1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Listeria sp Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Parainfluenza virus Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points:Arb:Pt:Bone mar:Ord:Molgen


name: t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points:Arb:Pt:Bone mar:Ord:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript:Arb:Pt:Bld/Tiss:Ord:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript:NCnc:Pt:Bld/Tiss:Qn:Molgen


name: t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript:PrThr:Pt:Bone mar:Ord:Molgen


name: Androstenedione^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^3H post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^2H post XXX challenge:CCnc:Pt:Plas:Qn


name: Vasopressin^30M post XXX challenge:MCnc:Pt:Plas:Qn


name: BK virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:ACnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LnCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:ACnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Herpes simplex virus 1+2 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 6 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes virus 7 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Herpes virus 8 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: JC virus DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:BAL:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Papova virus SV40 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Pneumocystis jiroveci DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Toxoplasma gondii DNA:NCnc:Pt:Amnio fld:Qn:Probe.amp.tar


name: Toxoplasma gondii DNA:NCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Platelet aggregation.ristocetin induced^1800 ug/mL:RelACnc:Pt:PRP:Qn


name: Microbiology section:-:-:^FDA package insert:Nar


name: BCR-ABL1 b2a2 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: BCR-ABL1 b3a2 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Hepatitis B virus surface Ab Actual/Negative control:RelACnc:Pt:Ser/Plas:Qn


name: Hepatitis B virus surface Ab Actual/Negative control


name: BCR-ABL1 e1a1 fusion protein:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Calcium oxalate dihydrate/Total:MFr:Pt:Calculus:Qn:Infrared spectroscopy


name: Calcium oxalate monohydrate/Total:MFr:Pt:Calculus:Qn:Infrared spectroscopy


name: CMT demyelinating gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Erythrocyte clumps:Naric:Pt:Urine sed:Qn:Automated count


name: MYOC gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: View^W contrast intra duct:Find:Pt:Breast>Breast duct.right:Doc:MG


name: View^W contrast intra duct:Find:Pt:Breast>Breast duct.left:Doc:MG


name: View runoff^WO & W contrast IA:Find:Pt:Lower extremity>Femoral artery:Doc:RF.angio


name: Influenza virus A H16 Ab:Titr:Pt:Ser:SemiQn:HAI


name: Influenza virus A H1 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H1 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A H3 Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus A H3 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H3 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A H5 Ab:PrThr:Pt:Ser:Ord


name: Influenza virus A H5 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H7 RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A H9 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Influenza virus A Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus A RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus A hemagglutinin type RNA:Prid:Pt:Isolate:Nom:Sequencing


name: Influenza virus B Ab:PrThr:Pt:Ser:Ord:IA


name: Influenza virus B Ag:PrThr:Pt:Isolate:Ord:IF


name: Influenza virus B RNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Influenza virus B RNA:Prid:Pt:Isolate:Nom:Sequencing


name: Influenza virus A & B RNA:Prid:Pt:Isolate:Nom:Probe.amp.tar


name: Influenza virus identified:Prid:Pt:XXX:Nom:Shell vial culture


name: Date and time of pheresis procedure:TmStp:Pt:^Patient:Qn


name: Newborn screening recommended follow-up:Imp:Pt:^Patient:Nom


name: Date referral lab test sent:TmStp:XXX:Referral lab test:Qn


name: Referral lab test method:Type:Pt:Referral lab test:Nar


name: Holoprosencephaly gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Troponin I.cardiac:MCnc:Pt:Ser/Plas:Qn:Detection limit <= 0.01 ng/mL


name: Epstein Barr virus band pattern:Imp:Pt:XXX:Nar:IB


name: Multisection^at rest+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection perfusion^W adenosine+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection perfusion^at rest+W stress+W Tl-201 IV+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection perfusion+wall motion^at rest+W stress+W Tl-201 IV+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Views GE 6:Find:Pt:Lower extremity.bilateral>Ankle:Doc:XR


name: Views limited^W I-131 MIBG IV:Find:Pt:XXX:Doc:NM


name: Second trimester triple maternal screen:Imp:Pt:Ser/Plas:Nar


name: Alpha-1-Fetoprotein multiple of the median cutoff:MoM:Pt:Ser/Plas:Qn


name: Alpha-1-Fetoprotein multiple of the median cutoff


name: First & Second trimester integrated maternal screen:Imp:Pt:^Patient:Nom


name: First trimester maternal screen with nuchal translucency:Imp:Pt:^Patient:Nar


name: Bacterial susceptibility panel:-:Pt:Isolate:OrdQn:Gradient strip


name: Calcidiol & Calciferol panel:-:Pt:Ser/Plas:-


name: Hepatitis B virus DNA:LaCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LaCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LaCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:CSF:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:Bone mar:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:XXX:Qn:Probe.amp.tar


name: Hepatitis B virus DNA:LaCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Hepatitis C virus genotype:Prid:Pt:Tiss:Nom:Probe.amp.tar


name: Hepatitis C virus RNA:LaCnc:Pt:Tiss:Qn:Probe.amp.tar


name: Bacterial carbapenem resistance blaKPC gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: SCA2 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: MJD gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: MJD gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: CACNA1A gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: CACNA1A gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA7 gene allele 1.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: SCA7 gene allele 2.CAG repeats:EntNum:Pt:Bld/Tiss:Qn:Molgen


name: HIV protease gene mutations:-:Pt:Isolate:-:Genotyping


name: HIV nonnucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV nonnucleoside reverse transcriptase susceptibility panel


name: HIV nucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV nucleoside reverse transcriptase susceptibility panel


name: HIV reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Genotyping


name: HIV reverse transcriptase susceptibility panel


name: HIV protease gene mutations:-:Pt:Isolate:-:Phenotyping


name: HIV nonnucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: HIV nucleoside reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: HIV reverse transcriptase susceptibility panel:-:Pt:Isolate:-:Phenotyping


name: Lymphocyte proliferation.100 umol beryllium stimulation^7D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.10 umol beryllium stimulation^5D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.10 umol beryllium stimulation


name: Lymphocyte proliferation.10 umol beryllium stimulation^7D post incubation:ACnc:Pt:Bld:Qn


name: Lymphocyte proliferation.1 umol beryllium stimulation^5D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.1 umol beryllium stimulation


name: Lymphocyte proliferation.1 umol beryllium stimulation^7D post incubation:Ratio:Pt:Bld:Qn


name: CPT2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Lymphocyte proliferation.phytohemagglutinin stimulation^3D post incubation:Ratio:Pt:Bld:Qn


name: ERBB2 gene copy number/Chromosome 17 copy number:NRto:Pt:Tiss:Qn:FISH


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:Bld:SemiQn


name: SH3TC2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: LMNA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ARSA gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: KCNQ2 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: TTR gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Deprecated Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy


name: Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 5 IU/mL


name: Hepatitis D virus Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Coagulation factor VII Ag actual/Normal:RelACnc:Pt:PPP:Qn:IA


name: FH gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: POU3F4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: ABCB4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Hydrogen/Expired gas^1.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^2H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^3H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Fetal lung maturity panel:-:Pt:Amnio fld:Qn


name: Cytokeratin 19 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cytokeratin 5 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Galectin 3 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Granzyme B Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Helicobacter pylori Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Serotonin release.heparin.low molecular weight interpretation:Imp:Pt:Ser:Nom


name: Serotonin release.heparin.low molecular weight interpretation


name: Serotonin release.heparin.low molecular weight panel:-:Pt:Ser:-


name: Serotonin release.heparin.low molecular weight panel


name: Serotonin release.heparin.porcine & low molecular weight panel:-:Pt:Ser:-


name: Serotonin release.heparin.porcine & low molecular weight panel


name: Guaranteed analysis of feed section:-:-:^FDA product label:Nar


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldC+Inhl gas:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldA+Inhl gas:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldMV+Inhl gas:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:BldV+Inhl gas:Qn


name: CMT demyelinating gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Mononuclear cells/100 leukocytes:NFr:Pt:Pericard fld:Qn


name: Polymorphonuclear cells/100 leukocytes:NFr:Pt:Pericard fld:Qn


name: Taenia solium larva Ab:ACnc:Pt:CSF:Qn:IA


name: 2-Hydroxyestrone & 16-Alpha hydroxyestrone panel:-:Pt:Ser/Plas:-


name: 2-Hydroxyestrone & 16-Alpha hydroxyestrone panel


name: Protein fractions.oligoclonal bands:Num:Pt:CSF:Qn:Isoelectric focusing


name: G6PC gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Coagulation factor VIII activity actual/Normal:RelACnc:Pt:PPP:Qn:Chromo


name: Herpes simplex virus 1 DNA:NCnc:Pt:Body fld:Qn:Probe.amp.tar


name: Herpes simplex virus 1 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Body fld:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Borrelia burgdorferi 18_20kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 18_20kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 18_20kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 18_20kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Hepatitis B virus codon 173:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 180:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 181:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 204:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 236:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus codon 80:Prid:Pt:Isolate:Nom:Genotyping


name: Hepatitis B virus resistance panel:-:Pt:Isolate:-:Genotyping


name: Lymphocyte proliferation.tetanus toxoid stimulation^7D post incubation:Ratio:Pt:Bld:Qn


name: Lymphocyte proliferation.beryllium stimulation panel:-:Pt:Bld:-


name: Lymphocyte proliferation.beryllium stimulation panel


name: Adenosine monophosphate.cyclic/Creatinine^1st specimen post XXX challenge:Ratio:Pt:Urine:Qn


name: Dehydroepiandrosterone^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^1H post dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone sulfate^pre dose corticotropin:MCnc:Pt:Ser/Plas:Qn


name: Human papilloma virus DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Somatotropin^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Histoplasma capsulatum M Ab:PrThr:Pt:CSF:Ord


name: Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda:MRto:24H:Urine:Qn


name: Japanese encephalitis virus Ab:Titr:Pt:CSF:SemiQn


name: Legionella pneumophila 1+2+3+4+5+6 Ab.IgM:PrThr:Pt:Ser:Ord


name: Lymphocyte proliferation.10 umol beryllium stimulation^6D post incubation:Ratio:Pt:WBC:Qn


name: Lymphocyte proliferation.concanavalin A stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation.concanavalin A stimulation


name: Lymphocyte proliferation.pokeweed mitogen stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation.pokeweed mitogen stimulation


name: Glucose-6-Phosphate dehydrogenase:CCnt:Pt:RBC:Qn:Glock & McLean


name: Serum/Plasma+Pleural fluid (thoracentesis fld)


name: Lactate dehydrogenase.plr fld/Lactate dehydrogenase.serum:RelRto:Pt:Ser/Plas+Plr fld:Qn


name: Specific gravity^^adjusted to pH 7.4:Rden:Pt:Urine:Qn


name: Urate renal clearance/1.73 sq M:ArVRat:XXX:Urine+Ser/Plas:Qn


name: Polymorphonuclear cells/100 leukocytes:NFr:Pt:Pericard fld:Qn:Manual count


name: Cortisol^1H post 250 ug corticotropin IM:SCncDiff:Pt:Ser/Plas:Qn


name: Cortisol^30M post 250 ug corticotropin IM:SCncDiff:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi 31kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 31kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 34kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 34kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 35kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 37kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Herpes simplex virus 1 DNA:NCnc:Pt:Bld:Qn:Probe.amp.tar


name: Borrelia burgdorferi 83_93kD Ab.IgG:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 83_93kD Ab.IgG:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 83_93kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 83_93kD Ab.IgM:PrThr:Pt:CSF:Ord:IB


name: Hydrogen/Expired gas^30M post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Indirect antiglobulin test.polyspecific reagent:PrThr:Pt:Ser/Plas:Ord:PEG


name: Hydrogen/Expired gas^2.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: West Nile virus Ag:PrThr:Pt:Bld/Bone mar^Donor:Ord


name: Hepatitis C virus RNA panel:-:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Virus identified:Prid:Pt:XXX:Nom:Shell vial culture


name: Fractional excretion of phosphate:Ratio:XXX:Urine+Ser/Plas:Qn


name: Fatty acids.very long chain.C24:0/Creatinine:SRto:Pt:Urine:Qn


name: Fatty acids.very long chain.C24:0/Creatinine


name: Urea renal clearance/1.73 sq M:ArVRat:XXX:Urine+Ser/Plas:Qn


name: 11-Hydroxyandrostenedione^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Hydroxyandrostenedione^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Hydroxyandrostenedione^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^45M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Ketosteroids^2D post dose dexamethasone:MCnc:Pt:Urine:Qn


name: 17-Hydroxypregnenolone^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxypregnenolone^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^pre 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^45M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^pre 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: 21-Deoxycortisol^1H post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Adenine phosphoribosyltransferase:CCnt:Pt:Amnio fld cells:Qn


name: Aldosterone^pre 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^30M post 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^1H post 250 ug corticotropin IM:SCnc:Pt:Ser/Plas:Qn


name: t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript:LnRto:Pt:Bld/Tiss:Qn:Molgen


name: Glomerular filtration rate/1.73 sq M.predicted:ArVRat:Pt:Ser/Plas/Bld:Qn:Cystatin C-based formula


name: Respiratory pathogens DNA & RNA 12a panel:-:Pt:XXX:-:Probe.amp.tar


name: Collection interval from baseline:Time:Pt:^Specimen:Qn


name: Oval fat bodies (globules):PrThr:Pt:Urine:Ord:Computer assisted


name: Leukocyte clumps:Naric:Pt:Urine sed:Qn:Automated count


name: Mixed cellular casts:PrThr:Pt:Urine:Ord:Computer assisted


name: 17-Ketosteroids^post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Ketosteroids^2D post high dose dexamethasone:MCnc:24H:Urine:Qn


name: 17-Ketosteroids^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^post high dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxycorticosteroids^2D post dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Hydroxypregnenolone^30M post 250 ug corticotropin:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^1st specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^2nd specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^3rd specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^4th specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Fatty acids.nonesterified^5th specimen post CFst:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^post 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre 25 mg captopril PO:SCnc:Pt:Ser/Plas:Qn


name: Deprecated Renal function panel & Glomerular filtration rate.predicted


name: Renal function panel & Glomerular filtration rate.predicted


name: 17-Ketosteroids^post high dose dexamethasone:MRat:24H:Urine:Qn


name: 17-Ketosteroids^2D post high dose dexamethasone:MRat:24H:Urine:Qn


name: 2-Dechloroethylifosfamide^1D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^3D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^4D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^5D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^3H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 2-Dechloroethylifosfamide^6H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: Deprecated 3-Hydroxytetradecanoylcarnitine (C14-OH) [Molecules/volume] in Serum or Plasma


name: 3-Dechloroethylifosfamide^1D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^3D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^4D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^6D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^3H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 3-Dechloroethylifosfamide^6H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^1D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^2D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^3D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^4D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^5D post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^3H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: 4-Hydroxyifosfamide^6H post dose ifosfamide:MCnc:Pt:Bld:Qn


name: Cyclospora sp identified:Prid:Pt:Stool:Nom:Safranin stain


name: Respiratory syncytial virus Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: SLC6A4 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Alpha-beta crystallin Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: carBAMazepine & metabolites panel:-:Pt:Ser/Plas:-


name: Deprecated Cholesterol [Mass/volume] in blood


name: Ependymal+Choroid plexus cells/100 leukocytes:Ratio:Pt:CSF:Qn


name: Ependymal+Choroid plexus cells/100 leukocytes


name: Parvovirus B19 DNA:PrThr:Pt:Body fld:Ord:Probe.amp.tar


name: Parvovirus B19 DNA:PrThr:Pt:Bone mar:Ord:Probe.amp.tar


name: Parvovirus B19 DNA:PrThr:Pt:Amnio fld:Ord:Probe.amp.tar


name: Platelet glycoprotein IIb-IIIa Ab:PrThr:Pt:Ser:Ord


name: Eosinophils.band form/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Myelocytes.eosinophilic/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Lupus anticoagulant neutralization.dilute phospholipid actual/Normal:RelTime:Pt:PPP:Qn:Coag


name: Lupus anticoagulant neutralization.dilute phospholipid actual/Normal


name: von Willebrand factor.collagen binding activity actual/Normal:RelRto:Pt:PPP:Qn:IA


name: von Willebrand factor.collagen binding activity/von Willebrand factor Ag:Ratio:Pt:PPP:Qn:IA


name: von Willebrand factor.collagen binding activity/von Willebrand factor Ag


name: Creatinine dialysis fluid clearance/1.73 sq M:ArVRat:Pt:Dial fld+Ser/Plas:Qn


name: Creatinine renal clearance/1.73 sq M.predicted.female:ArVRat:Pt:Ser/Plas:Qn:Cockcroft-Gault formula, BSA formula


name: Creatinine renal clearance/1.73 sq M.predicted.female


name: Creatinine renal clearance/1.73 sq M.predicted.male:ArVRat:Pt:Ser/Plas:Qn:Cockcroft-Gault formula, BSA formula


name: Creatinine renal clearance/1.73 sq M.predicted.male


name: Glomerular filtration rate/1.73 sq M.predicted:ArVRat:Pt:Ser/Plas/Bld:Qn:Creatinine-based formula (Schwartz)


name: Observation:Prid:Pt:Bronchial brush:Nom:Cyto stain.thin prep


name: Coagulation factor II circulating inhibitor:PrThr:Pt:PPP:Ord


name: Coagulation factor II circulating inhibitor


name: Coagulation surface induced circulating inhibitor:PrThr:Pt:PPP:Ord


name: Coagulation surface induced circulating inhibitor


name: Molecular diagnostic major findings for display:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Molecular diagnostic overall interpretation:PrThr:Pt:Bld/Tiss:Ord:Molgen


name: Molecular diagnostic overall interpretation


name: Body temperature^post transfusion reaction:Temp:Pt:^Patient:Qn


name: Blood group antibody titered:Prid:Pt:Ser/Plas:Nom


name: Blood pressure systolic & diastolic^post transfusion:Pres:Pt:Arterial system:Qn


name: Blood pressure systolic & diastolic^pre transfusion:Pres:Pt:Arterial system:Qn


name: Other cells/100 leukocytes:Prid:Pt:Synv fld:Nom


name: Patient symptoms^post transfusion reaction:Imp:Pt:^Patient:Nar


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid:Ratio:Pt:PPP:Qn:Coag


name: Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid


name: Corticotropin^pre 1 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Corticotropin^post 1 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Cortisol^pre 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^post 2 mg dexamethasone PO overnight:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^pre 2 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Corticotropin^post 2 mg dexamethasone PO overnight:MCnc:Pt:Plas:Qn


name: Corticotropin^pre 500 ug dexamethasone PO 2.5 day low dose q6h:MCnc:Pt:Plas:Qn


name: Corticotropin^post 500 ug dexamethasone PO 2.5 day low dose q6h:MCnc:Pt:Plas:Qn


name: Cortisol^pre 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^20M post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^40M post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1H post 100 ug CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^pre 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^20M post 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^40M post 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^1H post 100 ug CRH IV:MCnc:Pt:Plas:Qn


name: Cortisol^30M pre dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^20M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M pre dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^20M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Blasts.cytoplasmic CD22/100 blasts:NFr:Pt:Bone mar:Qn


name: Blasts.cytoplasmic CD3/100 blasts:NFr:Pt:Bone mar:Qn


name: Plasma cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Plasma cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: (Views) + (view AP^W standing):Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt:Find:Pt:Abdomen>Portal vein+Hepatic vein:Doc:RF.angio


name: Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt


name: Thyrotropin^20M post dose TRH:ACnc:Pt:Ser/Plas:Qn


name: Bacterial susceptibility panel:-:Pt:Isolate:OrdQn:Agar diffusion


name: Eastern equine encephalitis virus RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Urinalysis microscopic panel:NCnc:Pt:Urine:Qn:Automated count


name: Urinalysis dipstick panel:-:Pt:Urine:-:Test strip.automated


name: OTC - Keep out of reach of children section:-:-:^FDA product label:Nar


name: OTC - Keep out of reach of children section


name: OTC - Stop use section:-:-:^FDA product label:Nar


name: OTC - When using section:-:-:^FDA product label:Nar


name: OTC - Ask doctor or pharmacist section:-:-:^FDA product label:Nar


name: OTC - Ask doctor section:-:-:^FDA product label:Nar


name: OTC - Do not use section:-:-:^FDA product label:Nar


name: VFD Type C medicated feed animal drug label:-:-:^FDA product label:Nar


name: VFD Type C medicated feed animal drug label


name: VFD Type B medicated feed animal drug label:-:-:^FDA product label:Nar


name: VFD Type B medicated feed animal drug label


name: OTC Type C medicated feed animal drug label:-:-:^FDA product label:Nar


name: OTC Type C medicated feed animal drug label


name: OTC Type B medicated feed animal drug label:-:-:^FDA product label:Nar


name: OTC Type B medicated feed animal drug label


name: VFD Type A medicated article animal drug label:-:-:^FDA product label:Nar


name: VFD Type A medicated article animal drug label


name: OTC Type A medicated article animal drug label:-:-:^FDA product label:Nar


name: OTC Type A medicated article animal drug label


name: OTC animal drug label:-:-:^FDA product label:Nar


name: Prescription animal drug label:-:-:^FDA product label:Nar


name: Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel:-:Pt:Ser/Plas:-


name: Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel


name: Adenosine monophosphate.cyclic stimulation panel:-:Pt:Urine:Qn


name: Adenosine monophosphate.cyclic stimulation panel


name: Glucose tolerance gestational panel:-:Pt:Urine+Ser/Plas:-


name: Glucose screen gestational panel:-:Pt:Urine+Ser/Plas:-


name: Lactose challenge panel:-:Pt:Exhl gas:Qn


name: Triple bolus stimulation panel:-:Pt:Ser/Plas:Qn


name: Glucose tolerance 3H panel:-:-:Ser/Plas:Qn


name: Glucose tolerance 4H panel:-:-:Ser/Plas:Qn


name: Glucose tolerance 5H panel:-:-:Ser/Plas:Qn


name: Glucose tolerance 6H panel:-:-:Ser/Plas:Qn


name: Hydrogen/Expired gas^pre XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^4H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Neisseria meningitidis serogroups Ag panel:-:Pt:XXX:-:LA


name: Neisseria meningitidis serogroups Ag panel


name: Glucose tolerance 3H gestational panel:-:-:Ser/Plas:Qn


name: Alpha-1-Fetoprotein^^adjusted for multiple gestations:MoM:Pt:Ser/Plas:Qn


name: Chlamydophila pneumoniae Ab.IgA & IgG & IgM:Imp:Pt:Ser:Nom


name: Hydrogen/Expired gas^3.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^4.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^5.5H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^6H post XXX challenge:VFr:Pt:Exhl gas:Qn


name: HTT gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: AS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HIV 1 RNA panel:-:Pt:CSF:Qn:Probe.amp.tar


name: Ova & parasites:Prid:Pt:Bld/Tiss:Nom:Wright stain


name: DMD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Immunoglobulin heavy chain gene rearrangements:Find:Pt:Bld/Tiss:Nar:Molgen


name: Liver kidney microsomal Ab.IgG:Titr:Pt:Ser:SemiQn


name: Gentamicin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Cefepime:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Cefotaxime:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Coagulation factor XIII inhibitor:PrThr:Pt:PPP:Ord:Chromo


name: Bixa orellana seed Ab.IgE:ACnc:Pt:Ser:Qn


name: Human papilloma virus 6+11+42+43+44 DNA:PrThr:Pt:Anal:Ord:Probe.amp.sig


name: Latex recombinant (rHev b) 1 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 11 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 6.01 Ab.IgE:ACnc:Pt:Ser:Qn


name: Latex recombinant (rHev b) 6.02 Ab.IgE:ACnc:Pt:Ser:Qn


name: Lupinus albus seed Ab.IgE:ACnc:Pt:Ser:Qn


name: (Arachis hypogaea+Cow milk+Egg white+Mustard) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Actinidia chinensis+Beef+Pandalus borealis+Sesamum indicum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Anthoxanthum odoratum+Lolium perenne+Phleum pratense+Secale cereale+Holcus lanatus) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Actinidia chinensis+Corylus avellana+Musa spp+Pandalus borealis) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Corylus avellana+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Allium cepa+Allium sativum+Sesamum indicum+Yeast) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Basophils.band form/100 leukocytes:NFr:Pt:Bone mar:Qn


name: Herpes simplex virus 1 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes simplex virus 1 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Herpes simplex virus 2 DNA:NCnc:Pt:Urine:Qn:Probe.amp.tar


name: Nuclear matrix protein 22:PrThr:Pt:Urine:Ord


name: Semen analysis post vasectomy panel:-:Pt:Semen:-


name: First trimester maternal screen with nuchal translucency:Imp:Pt:^Patient:Nom


name: Thyroxine binding protein pattern:Imp:Pt:Ser/Plas:Nom:Electrophoresis


name: Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab:PrThr:Pt:Ser:Ord


name: Deprecated 11-Dehydro thromboxane beta 2/Creatinine [Mass Ratio] in Urine


name: 11-Dehydro thromboxane beta 2/Creatinine


name: Plasmodium sp lactate dehydrogenase:Prid:Pt:Bld:Nom


name: Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Parainfluenza virus 1+2+3 Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Influenza virus A+B Ab:Titr:Pt:Ser:SemiQn:Comp fix


name: Influenza virus A.neuraminidase inhibitor resistance:Susc:Pt:Isolate:Ord:Phenotyping


name: Influenza virus A nucleoprotein RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A non-structural protein RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A polymerase A RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A polymerase B1 cDNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus A polymerase B2 RNA:PrThr:Pt:Isolate:Ord:Sequencing


name: Influenza virus B Ab:Titr:Pt:Ser:SemiQn:HAI


name: Influenza virus susceptibility panel:-:Pt:Isolate:-


name: Influenza virus A polymerase RNA:Prid:Pt:Isolate:Nom:Sequencing


name: Influenza virus.neuraminidase inhibitor resistance:Susc:Pt:Isolate:Ord


name: Influenza virus.neuraminidase inhibitor resistance:Susc:Pt:Isolate:Ord:Genotyping


name: 11-Deoxycortisol^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 11-Deoxycortisol^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: VKORC1 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Lymphoblasts/100 leukocytes:NFr:Pt:Bone mar:Qn:Manual count


name: Monoblasts/100 leukocytes:NFr:Pt:Bone mar:Qn:Manual count


name: Reticulum cell/100 cells:NFr:Pt:Bone mar:Qn:Gomori stain


name: Serotonin release 100 IU/mL heparin.unfractionated:ACnc:Pt:Ser:Qn


name: Serotonin release 0.1 IU/mL heparin.unfractionated:ACnc:Pt:Ser:Qn


name: Serotonin release 100 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Serotonin release 0.1 IU/mL heparin.low molecular weight:ACnc:Pt:Ser:Qn


name: Safe handling warning section:-:-:^FDA product label:Nar


name: Environmental warning section:-:-:^FDA product label:Nar


name: Food safety warning section:-:-:^FDA product label:Nar


name: Information for owners or caregivers section:-:-:^FDA product label:Nar


name: Information for owners or caregivers section


name: Veterinary indications section:-:-:^FDA product label:Nar


name: Platelet factor 4 Ag:PrThr:Pt:PPP:Ord:IA


name: Glucose^15M post 0.1 U/kg insulin:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^15M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral:Doc:CT


name: Herpes simplex virus 1 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Coagulation surface induced.lupus sensitive.factor substitution^1H post incubation after addition of normal plasma:Time:Pt:PPP:Qn:Coag


name: Ganglioside GD1a Ab.IgG/Ganglioside GD1a Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GD1a Ab.IgG/Ganglioside GD1a Ab.IgM


name: Ganglioside GD1b Ab.IgG/Ganglioside GD1b Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GD1b Ab.IgG/Ganglioside GD1b Ab.IgM


name: Asialoganglioside GM1 Ab.IgG/Asialoganglioside GM1 Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Asialoganglioside GM1 Ab.IgG/Asialoganglioside GM1 Ab.IgM


name: Ganglioside GM1 Ab.IgG/Ganglioside GM1 Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GM1 Ab.IgG/Ganglioside GM1 Ab.IgM


name: Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM


name: Ganglioside GQ1b Ab.IgG/Ganglioside GQ1b Ab.IgM:Ratio:Pt:Ser:Qn:IA


name: Ganglioside GQ1b Ab.IgG/Ganglioside GQ1b Ab.IgM


name: ABO & Rh group^post transfusion reaction:Type:Pt:Bld^Newborn:Nom


name: Primary reason for assessment:Type:Pt:^Patient:Nom:MDS.full


name: Hemoglobin pattern:Imp:Pt:Bld:Nom:Electrophoresis pH 6.0


name: XXX blood group Ab.IgM:Titr:Pt:Ser/Plas:SemiQn


name: Hepatitis B virus surface Ag:PrThr:Pt:Bld^Donor:Ord:Neut


name: Epstein Barr virus early diffuse Ab.IgG:ACnc:Pt:Ser:Qn


name: XXX blood group Ab:Titr:Pt:Ser/Plas:SemiQn:Antihuman globulin


name: Paragonimus sp Ab:Titr:Pt:Plr fld:SemiQn


name: Parainfluenza virus 1+2+3 Ab:Titr:Pt:Ser:SemiQn


name: Calcium.ionized^^adjusted to pH 7.4:SCnc:Pt:Body fld:Qn


name: Mycobacterium sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: Reasons for assessment (full):-:Pt:^Patient:Set


name: Platelet aggregation.adenosine diphosphate induced^20 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.adenosine diphosphate induced^2 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.adenosine diphosphate induced^4 umol/L:PrThr:Pt:PRP:Ord


name: Platelet aggregation.collagen induced^190 ug/mL:PrThr:Pt:PRP:Ord


name: Indirect antiglobulin test.XXX reagent^post transfusion:PrThr:Pt:Ser/Plas:Ord


name: Indirect antiglobulin test.XXX reagent:PrThr:Pt:Ser/Plas:Ord


name: XXX blood group Ab.IgG:Titr:Pt:Ser/Plas:SemiQn


name: Cytology report:Find:Pt:Bronchial brush:Doc:Cyto stain


name: pH^^adjusted to patient's actual temperature:LsCnc:Pt:BldMV:SemiQn


name: Carbon dioxide^^adjusted to patient's actual temperature:PPres:Pt:BldMV:Qn


name: Horowitz index^^adjusted to patient's actual temperature:Ratio:Pt:Bld+Inhl gas:Qn


name: BRCA1+BRCA2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: HBB gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CFTR gene mutations tested for:Num:Pt:Bld/Tiss:Qn:Molgen


name: Leishmania donovani Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Leishmania tropica Ab.IgG & IgM:Imp:Pt:Ser:Nar


name: Direct antiglobulin test.XXX reagent:PrThr:Pt:RBC:Ord


name: Direct antiglobulin test.XXX reagent^post transfusion:PrThr:Pt:RBC:Ord


name: Triticum aestivum native (nTri a) 19 Ab.IgE:ACnc:Pt:Ser:Qn


name: Blasts.cytoplasmic CD117/100 cells:NFr:Pt:Bone mar:Qn


name: Blasts.cytoplasmic CD13/100 blasts:NFr:Pt:Bone mar:Qn


name: Blasts.cytoplasmic CD179a/100 blasts:NFr:Pt:Bone mar:Qn


name: CD117 Ag:PrThr:Pt:Bone mar:Ord:Immune stain


name: CD15 Ag:PrThr:Pt:Bone mar:Ord:Immune stain


name: Mononuclear cells/100 leukocytes:NFr:Pt:Bld:Qn:Manual count


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG:MCnc:Pt:Ser:Qn:IA


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG2:MCnc:Pt:Ser:Qn:IA


name: 17-Hydroxyprogesterone^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Testosterone^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Aldosterone^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Corticotropin^pre or post XXX challenge:SCnc:Pt:Plas:Qn


name: Cortisol^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: EPINEPHrine^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Insulin^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lactate^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Norepinephrine^pre or post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Calcitonin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Gastrin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^pre or post XXX challenge:MCnc:Pt:Plas:Qn


name: Somatotropin^pre or post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Paragonimus sp Ab:Titr:Pt:Plr fld:SemiQn:IA


name: Coccidioides immitis Ab:Titr:Pt:Body fld:SemiQn


name: Epstein Barr virus early diffuse Ab:PrThr:Pt:CSF:Ord


name: Influenza virus A H16 Ab:Titr:Pt:Ser:SemiQn


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG:MCnc:Pt:Ser:Qn


name: Streptococcus pneumoniae capsular polysaccharide Ab.IgG2:MCnc:Pt:Ser:Qn


name: ABCB4 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Coccidioides sp Ab.IgM:PrThr:Pt:XXX:Ord:Immune diffusion


name: 10 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: 1 minute post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: 2 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: 5 minutes post 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: after addition of normal plasma 1 hour post incubation separate tubes


name: pre 2 mg/kg calcium and 0.5 ug/kg pentagastrin IV


name: Glomerular filtration rate/1.73 sq M.predicted


name: Anticoagulants, pro- and antifibrinolytics


name: Glomerular filtration rate/1.73 sq M.predicted.female


name: Ciliated columnar lining cells/100 leukocytes


name: Miscellaneous toxic small organic and inorganic molecules


name: Nucleic acid amplification detection limit = 5 iU/mL


name: Bretville hypospadias repair - first stage


name: Turner-Warwick hypospadias repair - first stage


name: {21 (ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) } Pack


name: {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) } Pack


name: BANDAGE TUBULAR ELASTIC PADDED LARGE C#154581


name: BANDAGE TUBULAR ELASTIC PADDED MEDIUM C#154580


name: BANDAGE TUBULAR ELASTIC PADDED SMALL C#154579


name: BANDAGE,ELASTIC,CONFORMING (MOLLELAST) 1.6IN X 4.4YD


name: BARRIER,ASSURA PEDIATRIC COLOPLAST #2182


name: BELT,ELASTIC 1.5IN WITH PLASTIC BUCKLES NU-HOPE #2610


name: BELT,ELASTIC 1IN WITH PLASTIC BUCKLE NU-HOPE #2600


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2663DC


name: BELT,SUPPORT 4IN X-LARGE NU-HOPE #2668-H


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6604-P


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6604-PC


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6614-B


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6614-PC


name: BELT,SUPPORT 6IN XX-LARGE NU-HOPE #6614-SP


name: DRESSING,ACTICOAT ROPE 0.75IN X 12IN SN#20181


name: BELT,SUPPORT 9IN X-LARGE NU-HOPE #6643-SP


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR LARGE ATTENDS


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR MEDIUM ATTENDS


name: BRIEF,EXTRA ABSORBENT PROTECTIVE UNDERWEAR X-LARGE ATTENDS


name: BRIEF,SUPER PLUS ABSORB WITH BARRIERS UNDERWEAR LARGE ATTENDS


name: BRIEF,SUPER PLUS ABSORB WITH BARRIERS UNDERWEAR MEDIUM ATTENDS


name: BRIEF,SUPER PLUS ABSORB WITH BARRIERS UNDERWEAR X-LARGE ATTENDS


name: CATHETER FOLEY 2-WAY SPECIALTY 5CC BARD#0196SI16


name: CATHETER,EXTERNAL INTERMEDIATE FREEDOM CLEAR #5300/5330


name: CATHETER,EXTERNAL INTERMEDIATE FREEDOM CLEAR SS #5310


name: CATHETER,EXTERNAL LARGE FREEDOM CLEAR #5400/5430


name: CATHETER,EXTERNAL LARGE FREEDOM CLEAR SS #5410


name: CATHETER,EXTERNAL MEDIUM FREEDOM CLEAR #5200/5230


name: CATHETER,EXTERNAL MEDIUM FREEDOM CLEAR SS #5210